253 related articles for article (PubMed ID: 34283938)
1. Knockdown of lysyl oxidase like 1 inhibits the proliferation and pro-fibrotic effects of transforming growth factor-β1-induced hypertrophic scar fibroblasts.
Ying M; Chen Y; Yuan B
Can J Physiol Pharmacol; 2021 Dec; 99(12):1272-1279. PubMed ID: 34283938
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of LOXL1 inhibits TGF-β1-induced proliferation and fibrogenesis of hepatic stellate cells by inhibition of Smad2/3 phosphorylation.
Ma L; Zeng Y; Wei J; Yang D; Ding G; Liu J; Shang J; Kang Y; Ji X
Biomed Pharmacother; 2018 Nov; 107():1728-1735. PubMed ID: 30257391
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Pathological Phenotype of Hypertrophic Scar Fibroblasts Via Coculture with Adipose-Derived Stem Cells.
Deng J; Shi Y; Gao Z; Zhang W; Wu X; Cao W; Liu W
Tissue Eng Part A; 2018 Mar; 24(5-6):382-393. PubMed ID: 28562226
[TBL] [Abstract][Full Text] [Related]
4. SPARC knockdown attenuated TGF-β1-induced fibrotic effects through Smad2/3 pathways in human pterygium fibroblasts.
Fan J; Zhang X; Jiang Y; Chen L; Sheng M; Chen Y
Arch Biochem Biophys; 2021 Nov; 713():109049. PubMed ID: 34624278
[TBL] [Abstract][Full Text] [Related]
5. MiR-15b and miR-16 suppress TGF-β1-induced proliferation and fibrogenesis by regulating LOXL1 in hepatic stellate cells.
Ma L; Liu J; Xiao E; Ning H; Li K; Shang J; Kang Y
Life Sci; 2021 Apr; 270():119144. PubMed ID: 33545201
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of FOXM1 inhibits activation of keloid fibroblasts and extracellular matrix production via inhibition of TGF-β1/Smad pathway.
Zhang Y; Cheng C; Wang S; Xu M; Zhang D; Zeng W
Life Sci; 2019 Sep; 232():116637. PubMed ID: 31288014
[TBL] [Abstract][Full Text] [Related]
7. Thrombospondin-4 critically controls transforming growth factor β1 induced hypertrophic scar formation.
Qian W; Li N; Cao Q; Fan J
J Cell Physiol; 2018 Jan; 234(1):731-739. PubMed ID: 30132849
[TBL] [Abstract][Full Text] [Related]
8. Corilagin alleviates hypertrophic scars via inhibiting the transforming growth factor (TGF)-β/Smad signal pathway.
Li Y; Yu Z; Zhao D; Han D
Life Sci; 2021 Jul; 277():119483. PubMed ID: 33862115
[TBL] [Abstract][Full Text] [Related]
9. Ellagic acid inhibits the formation of hypertrophic scars by suppressing TGF-β/Smad signaling pathway activity.
Zhao ZJ; Wu DJ; Lv DL; Zhang BD; Chen L; Sun YQ
Chem Biol Drug Des; 2023 Oct; 102(4):773-781. PubMed ID: 37386691
[TBL] [Abstract][Full Text] [Related]
10. Silencing NLRC5 inhibits extracellular matrix expression in keloid fibroblasts via inhibition of transforming growth factor-β1/Smad signaling pathway.
Ma HL; Zhao XF; Chen GZ; Fang RH; Zhang FR
Biomed Pharmacother; 2016 Oct; 83():1016-1021. PubMed ID: 27525969
[TBL] [Abstract][Full Text] [Related]
11. LncRNA HOTAIR promotes endometrial fibrosis by activating TGF-β1/Smad pathway.
Wu J; Jin L; Zhang Y; Duan A; Liu J; Jiang Z; Huang L; Chen J; Liu Z; Lu D; Dai Y
Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(12):1337-1347. PubMed ID: 33313721
[TBL] [Abstract][Full Text] [Related]
12. Umbilical cord-derived mesenchymal stem cells exert anti-fibrotic action on hypertrophic scar-derived fibroblasts in co-culture by inhibiting the activation of the TGF β1/Smad3 pathway.
Meng X; Gao X; Chen X; Yu J
Exp Ther Med; 2021 Mar; 21(3):210. PubMed ID: 33574910
[TBL] [Abstract][Full Text] [Related]
13. Exosomes derived from human adipose mesenchymal stem cells attenuate hypertrophic scar fibrosis by miR-192-5p/IL-17RA/Smad axis.
Li Y; Zhang J; Shi J; Liu K; Wang X; Jia Y; He T; Shen K; Wang Y; Liu J; Zhang W; Wang H; Zheng Z; Hu D
Stem Cell Res Ther; 2021 Mar; 12(1):221. PubMed ID: 33789737
[TBL] [Abstract][Full Text] [Related]
14. miR-145-5p attenuates hypertrophic scar via reducing Smad2/Smad3 expression.
Shen W; Wang Y; Wang D; Zhou H; Zhang H; Li L
Biochem Biophys Res Commun; 2020 Jan; 521(4):1042-1048. PubMed ID: 31732152
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor β1 promotes fibroblast-like synoviocytes migration and invasion via TGF-β1/Smad signaling in rheumatoid arthritis.
Zhu D; Zhao J; Lou A; Huang Q; OuYang Q; Zhu J; Fan M; He Y; Ren H; Yang M
Mol Cell Biochem; 2019 Sep; 459(1-2):141-150. PubMed ID: 31297660
[TBL] [Abstract][Full Text] [Related]
16. Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-β/Smad pathway.
Bai X; He T; Liu J; Wang Y; Fan L; Tao K; Shi J; Tang C; Su L; Hu D
Exp Dermatol; 2015 May; 24(5):355-60. PubMed ID: 25683490
[TBL] [Abstract][Full Text] [Related]
17. Smad2 and Smad3 as mediators of the response of adventitial fibroblasts induced by transforming growth factor β1.
Ren M; Wang B; Zhang J; Liu P; Lv Y; Liu G; Jiang H; Liu F
Mol Med Rep; 2011; 4(3):561-7. PubMed ID: 21468608
[TBL] [Abstract][Full Text] [Related]
18. SnoN residue (1-366) attenuates hypertrophic scars through resistance to transforming growth factor-β1-induced degradation.
Sun GF; Li HC; Zhan YP; Zhang XF; Pan LY; Chen YF; Xu K; Feng DX
Lab Invest; 2019 Dec; 99(12):1861-1873. PubMed ID: 31409891
[TBL] [Abstract][Full Text] [Related]
19. USP15 Enhances the Proliferation, Migration, and Collagen Deposition of Hypertrophic Scar-Derived Fibroblasts by Deubiquitinating TGF-βR1 In Vitro.
Tu L; Lin Z; Huang Q; Liu D
Plast Reconstr Surg; 2021 Nov; 148(5):1040-1051. PubMed ID: 34546211
[TBL] [Abstract][Full Text] [Related]
20. LncRNA PICSAR binds to miR-485-5p and activates TGF-β1/Smad to promote abnormal proliferation of hypertrophic scar fibroblasts (HSFs) and excessive deposition of extracellular matrix (ECM).
Xu S; Dong W; Shi Y
Med Mol Morphol; 2021 Dec; 54(4):337-345. PubMed ID: 34255190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
